Clinical Trials Sponsored by Pharma Agency

Total 10116 results

Monsea Ltd.
Harmonium International Inc.; Pharma Agency

Completed

Prevention of Irinotecan Induced Diarrhea by Probiotics

Colorectal Cancer

Slovakia
British Columbia Cancer Agency
Roche Pharma AG

Recruiting

PRecision Oncology Evidence Development in Cancer Treatment - Liquid (PREDiCTl)

Cancer

Canada
Astellas Pharma Inc
Agensys, Inc.

Completed

A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer

Pancreatic Cancer | Pancreatic Disease | Carcinoma, Pancreatic Ductal

Canada, United States, Spain, France, Russian Federation
Astellas Pharma Inc
Agensys, Inc.

Completed

AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer

Prostate Cancer

United States
Astellas Pharma Inc
Agensys, Inc.

Terminated

A Phase 1 Study of the Safety and Pharmacokinetics of AGS-16M18 in Subjects With Advanced Renal Cell Cancer

Kidney Neoplasms | Carcinoma, Renal Cell | Kidney Diseases

United States
Astellas Pharma Inc
Agensys, Inc.

Terminated

A Study of the Safety and Pharmacokinetics of AGS-8M4 Given in Combination With Chemotherapy in Women With Ovarian Cancer

Carcinoma | Ovarian Diseases | Ovarian Neoplasms | Ovarian Cancer

United States
Astellas Pharma Inc
Agensys, Inc.

Completed

A First in Man Study to Determine the Safety at Various Dose Levels of AGS-16M8F in Advanced Kidney Cancer

Renal Cell Carcinoma | Pharmacokinetics of AGS-16M8F

United States
Agensys, Inc.

Completed

A Study to Assess the Safety, Pharmacokinetics and Effectiveness of AGS-16C3F Monotherapy in Subjects With Renal Cell Carcinoma (RCC) of Clear Cell or Papillary Histology

Carcinoma, Renal Cell | Renal Cell Carcinoma of Papillary Histology | Renal Cell Carcinoma With Clear Cell Histology | Renal Cell Carcinoma With Non-Clear Cell Histology

United States, Canada
Agensys, Inc.

Completed

A Study of AGS-1C4D4 in Pancreatic Cancer Subjects Previously Treated in Protocol 2008002

Pancreatic Cancer | Pancreatic Disease | Carcinoma, Pancreatic Ductal

United States, Canada
Astellas Pharma Inc
Agensys, Inc.

Completed

A Phase 1 Study of the Safety and Pharmacokinetics of AGS-8M4 in Subjects With Advanced Ovarian Cancer

Carcinoma | Ovarian Diseases | Ovarian Neoplasms | Ovarian Cancer

United States
Institut Curie
Roche Pharma AG; National Research Agency, France

Not yet recruiting

Early Detection of Triple Negative Breast Cancer Relapse (CUPCAKE)

Triple Negative Breast Cancer

France
Rennes University Hospital
Roche Pharma AG; National Research Agency, France

Completed

BMS_PD-L1_onco : Assessment of the PD-L1 Protein as a Biomarker in Oncology and Hematology (BMS_PD-L1)

Hodgkin Lymphoma | Non-small Cell Lung Cancer | Diffuse Large B-cell Lymphoma | Metastatic Breastcancer

France
R-Pharm
Covance; Cromos Pharma LLC

Withdrawn

Study of the Efficacy and Safety of a Single Administration of Olokizumab vs. Placebo in Addition to Standard Treatment in Patients With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection (COVID-19).

COVID-19
Zealandina Agency

Completed

Mountain Food and Natural Probiotic in Nutrition

Immune Deficiency

United Kingdom
Astellas Pharma Inc
Seagen Inc.; Agensys, Inc.

Completed

A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4

Neoplasms | Tumors | Medical Oncology

United States, Canada
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

Open-label Study to Assess the Safety and Efficacy of CDP6038 (Olokizumab) in Patients Who Completed RA0056

Rheumatoid Arthritis

United States, Belgium, United Kingdom
AJU Pharm Co., Ltd.
OM Pharma SA

Recruiting

The Efficacy and Safety of OM-89 in Patients With Recurrent Chronic Prostatitis/Chronic Pelvic Pain Syndrome

Chronic Prostatitis With Chronic Pelvic Pain Syndrome | Chronic Prostatitis | Chronic Pelvic Pain Syndrome

Korea, Republic of
UCB BIOSCIENCES, Inc.
R-Pharm

Terminated

The Long-term Safety and Efficacy of CDP6038 (Olokizumab) With Active Rheumatoid Arthritis

Rheumatoid Arthritis

Japan, Korea, Republic of, Taiwan
Yuria-Pharm
Pharmaxi LLC

Completed

Epidemiological Study of the COVID-2019 in Participating Organizations.

Covid19

Ukraine
Assistance Publique - Hôpitaux de Paris
Agence Nationale de Recherche (ANR) National Research Agency

Completed

Impact of the COVID-19 Pandemic on Mental Health Service Utilization in Children and Adolescents (MENTALPED)

Mental Disorder, Child

France
Valencian Innovation Agency

Not yet recruiting

Evaluation of the Colonization Capacity of a Probiotic Bacterium. (BIOPRED)

Obese | Weight, Body

Spain
Komagome Hospital
Japan Agency for Medical Research and Development; Prism Pharma Co., Ltd.

Completed

An Open Label, Single Arm, Dose Escalation Phase 1 Trial of PRI-724 in Patients With HCV-induced Cirrhosis

Hepatitis C Virus-infected Cirrhosis

Japan
Komagome Hospital
Japan Agency for Medical Research and Development; Prism Pharma Co., Ltd.

Completed

A Follow-up Evaluation Study of PRI-724-1101

Hepatitis C Virus-infected Cirrhosis

Japan
Groupe d'Etude sur le Risque d'Exposition des Soignants...
Agence Regionale de Sante d'Ile de France; National Agency of Public Health

Completed

GriCoVax Study in 4 Maternity Wards in the Ile-de-France Region (GriCoVax)

Pregnant Women | Influenza Vaccination | Pertussis Vaccine | Healthcare Worker Patient Transmission

France
British Columbia Cancer Agency

Not yet recruiting

PATH Trial: Personalized Approaches in the Treatment of Head and Neck Cancer (PATH)

Head and Neck Cancer
British Columbia Cancer Agency

Recruiting

PRecision Oncology Evidence Development in Cancer Treatment - Clinical: PREDiCTc (PREDiCTc)

Cancer

Canada
British Columbia Cancer Agency

Recruiting

[68Ga]Ga-PSMA-11 PET/CT in the Assessment of High Risk and Recurrent Prostate Cancer

Prostatic Cancer | Prostatic Neoplasm

Canada
British Columbia Cancer Agency

Recruiting

PROstate Cancer TReatment Optimization Via Analysis of Circulating Tumour DNA (PROTRACT)

Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Canada
British Columbia Cancer Agency

Recruiting

PSMA PET/CT for Assessment of Recurrent Prostate Cancer

Prostatic Neoplasms | Prostate Cancer

Canada
Environmental Protection Agency (EPA)

Enrolling by invitation

Modification of Ambient Air Pollution Exposure and Cardiopulmonary Outcomes by Socioeconomic Status and Nutrition (SENSE)

Air Pollution | Pollution; Exposure | Nutrition, Healthy

United States
British Columbia Cancer Agency

Withdrawn

177Lu-DOTATOC for the Treatment of Patients With Somatostatin Receptor Positive NETs

Neuroendocrine Tumors | Carcinoid Tumor | Gastrinoma | Insulinoma | Vipoma | Gastroenteropancreatic Neuroendocrine Tumor | Pulmonary Carcinoid Tumor

Canada
British Columbia Cancer Agency

Withdrawn

FDGal PET/CT to Detect Hepatocellular Carcinoma

Liver Cirrhosis | Hepatocellular Carcinoma | Chronic Liver Disease

Canada
British Columbia Cancer Agency

No longer available

18F-FDOPA PET in Neuroendocrine Tumours

Thyroid Cancer, Medullary | Neuroblastoma | Pheochromocytoma | Carcinoid Tumor | Paraganglioma | Insulinoma

Canada
British Columbia Cancer Agency

Active, not recruiting

Stereotactic Ablative Body Radiotherapy (SABR) for Oligometastases

Metastatic Tumors

Canada
Environmental Protection Agency (EPA)

Completed

Responses to Exposure to Low Levels of Concentrated Ambient Particles in Healthy Young Adults (RECAP)

Exposure to Pollution

United States
British Columbia Cancer Agency

Completed

High Dose Rate Prostate Brachytherapy: Dose Escalation to Dominant Intra-prostatic Nodule (Dosepainting)

Prostate Cancer

Canada
British Columbia Cancer Agency

Unknown

Detection of Covid-19 by Volatile Organic Compounds in Exhaled Breath (Covid-VOC)

Covid19

Canada
British Columbia Cancer Agency

Completed

18F-AmBF3-TATE PET/CT for Imaging NET Patients

Neuroendocrine Tumors

Canada
Environmental Protection Agency (EPA)

Completed

Epigenetic Effect Modifications With Ozone Exposure on Healthy Volunteers (Geminoz)

Exposure to Environmental Pollution, Non-occupational

United States
British Columbia Cancer Agency

Completed

18F-fluorodeoxyglucose (18F-FDG) Positron Emission Tomography in Oncology

Melanoma | Lymphoma | Lung Neoplasms | Colorectal Neoplasms | Brain Neoplasms

Canada
British Columbia Cancer Agency

Unknown

Prophylactic Gabapentin for Taxane-Induced Arthralgia and Myalgia Syndrome in Breast Cancer Patients Undergoing Adjuvant Chemotherapy

Arthralgia | Myalgia | Invasive Breast Cancer | Chemotherapeutic Toxicity
Environmental Protection Agency (EPA)

Completed

The Interaction of Social Factors With Air Pollution (SOZIAL)

Exposure to Environmental Pollution, Non-occupational

United States
British Columbia Cancer Agency

Unknown

Feasibility Study of MRI Imaging on Parotid Gland Stimulation (SPIT)

Parotid Neoplasms

Canada
British Columbia Cancer Agency

Withdrawn

Dose Escalation Trial of Neoadjuvant Sorafenib and Concurrent Sorafenib, Cisplatin and Radiation in Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Locally Advanced Squamous Cell Carcinomas of the Head and Neck (SCCHN)

Canada
Environmental Protection Agency (EPA)

Completed

Epigenetic Effects of Diesel Exhaust and Ozone Exposure (Lamarck)

Exposure to Pollution | Inhalation of Ozone

United States
British Columbia Cancer Agency

Unknown

Trial of Argon Plasma Coagulation Versus APC and APC and Hemospray in the Treatment of Radiation Proctitis

Rectal Bleeding

Canada
British Columbia Cancer Agency

Unknown

Randomized Anastrozole Exercise Trial (RAE)

Musculoskeletal Symptoms

Canada
British Columbia Cancer Agency

Completed

Evaluation of the Informational Content of Setup Verification Images for Patients Receiving Breast Radiation Therapy (Anterior EPI) (Anterior EPI)

Breast Cancer

Canada
Environmental Protection Agency (EPA)

Completed

Cardiovascular Effects of Incremental Diesel Exhaust Inhalation in Middle-Aged Healthy GSTM1 Null Human Volunteers

Healthy

United States
International Atomic Energy Agency

Completed

Trial of Five Versus Six Fractions Per Week for Head and Neck Cancer

Head and Neck Cancer

Clinical Trials Sponsored by Pharma Agency

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Jamaica

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations